MS, Marijuana, Pain and Spasticity Study -2018 Jul

MS, Marijuana, Pain and Spasticity Study -2018 Jul

In 2018, After a review of scientific studies, researchers say extracts from marijuana plants can help treat pain and spasticity symptoms in people with multiple sclerosis. Background: looked at the safety and effectiveness of cannabis as well as studying its impact on disability and disability progression, pain, spasticity, bladder function, tremor/ataxia, quality of life, and .. Read More

Neuropathic Pain & Cannibinoids-2009 Oct

In 2009, Cannabinoids as pharmacotherapies for neuropathic pain: nerve injury, diabetes, chemotherapeutic treatment, human immunodeficiency virus, multiple sclerosis, and herpes zoster infection is considered. Background: review of clinical and preclinical literature evaluating CB1, CB2, THC You can read the full article here =>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755639/

Pain Management Study for Elderly-2018 Mar

In 2018, Studied the safety and efficacy of medical cannabis in elderly treatments of 2736 patients.  Background: A prospective study that included all patients above 65 years of age who received medical cannabis from January 2015 to October 2017. You can read the full article here => https://multiplesclerosisnewstoday.com/2018/02/20/medical-cannabis-treats-chronic-pain-older-multiple-sclerosis-other-patients-report/?utm_content=buffer09fa0&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

MS Symptoms & Cannabis Study-2012 Nov

In 2012, A 12 week study using Cannabis Extract for muscle stiffness associated with Multiple Sclerosis Patients aged 18-64 years  Background: Double blind, placebo controlled, with a 2 week dose titration phase from 5 mg to a maximum of 25 mg of THC daily and a 10 week maintenance phase. You can read the full article here => https://www.researchgate.net/publication/229082908_MUltiple_Sclerosis_and_Extract_of_Cannabis_results_of_the_MUSEC_trial

MS Neuropathic Pain Clinical Study-2007 Dec

In 2007, Uncontrolled patient trial of THC/cannabidiol for neuropathic pain associated with multiple sclerosis with a 2-year extension trial. Background: 64 males completed the randomized trial and 63 entered the open-label extension. age, range, 27–71 years. You can read the full article here => http://www.clinicaltherapeutics.com/article/S0149-2918(07)00294-9/

MS Research-2012 Jun

In 2012, MS has been considered mainly an inflammatory disorder, recent evidence, however, revealed the importance of neurodegenerative events, opening the possibility to cannabinoid treatment. Mice were used BACKGROUND: Treatment with WIN55,512-2, a potent CB1 and CB2agonist, was reported to be effective to ameliorate tremor and spasticity in mice with chronic relapsing experimental autoimmune encephalomyelitis, You .. Read More

Join the waitlist for our upcoming Releasing Chronic Pain Class Coming in 2022.